Profil
Mark Vainisi is currently the Director at Shields Specialty Pharmacy Holdings LLC and the Executive VP-Corporate Development & Strategy at Village Practice Management Co. LLC.
He previously served as an Independent Director at Option Care Health, Inc. from 2019 to 2023, Vice President-Mergers & Acquisitions at Walgreen Co. from 2005 to 2015, and Senior VP-Global Mergers & Acquisitions at Walgreens Boots Alliance, Inc. from 2015 to 2022.
Mr. Vainisi obtained undergraduate and doctorate degrees from the University of Michigan.
Postes actifs de Mark Vainisi
| Sociétés | Poste | Début |
|---|---|---|
Village Practice Management Co. LLC
Village Practice Management Co. LLC Medical/Nursing ServicesHealth Services Operates healthcare clinics | Corporate Officer/Principal | 01/01/2020 |
Shields Specialty Pharmacy Holdings LLC
Shields Specialty Pharmacy Holdings LLC Part of Shields Health Solutions Holdings LLC, Shields Specialty Pharmacy Holdings LLC is a specialty pharmacy integrator and accelerator that partners with health systems to improve patient outcomes and expand access to specialty medications for chronic, complex, and rare diseases. The company is based in Stoughton. The American company offers an integrated, patient-centered care model supported by clinical teams and proprietary technology, including the telemetryrx® platform, which uses data analytics to enhance medication adherence, therapy management, and payer access. Shields provides services such as specialty pharmacy operations, pharmaceutical pipeline management, payer contracting, trade relations, 340b strategy, revenue cycle support, and compliance monitoring. The company manages limited distribution drugs and complex therapies for conditions like hereditary angioedema, myasthenia gravis, pulmonary arterial hypertension, multiple sclerosis, hepatitis c, hiv, and rheumatoid arthritis. Shields collaborates with health systems to build and accelerate specialty pharmacy programs, optimize drug launches, and improve clinical and financial outcomes. | Directeur/Membre du Conseil | 01/01/2020 |
Anciens postes connus de Mark Vainisi
| Sociétés | Poste | Fin |
|---|---|---|
| OPTION CARE HEALTH, INC. | Directeur/Membre du Conseil | 17/05/2023 |
| WALGREENS BOOTS ALLIANCE, INC. | Corporate Officer/Principal | 01/01/2022 |
Walgreen Co.
Walgreen Co. Drugstore ChainsRetail Trade Retails pharmaceutical and healthcare products through instore & online | Corporate Officer/Principal | 01/01/2015 |
Formation de Mark Vainisi
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Walgreen Co.
Walgreen Co. Drugstore ChainsRetail Trade Retails pharmaceutical and healthcare products through instore & online | Retail Trade |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Walgreens Boots Alliance, Inc.
Walgreens Boots Alliance, Inc. Drugstore ChainsRetail Trade Retails and wholesales pharmaceuticals & provides technology-enabled healthcare services | Retail Trade |
Village Practice Management Co. LLC
Village Practice Management Co. LLC Medical/Nursing ServicesHealth Services Operates healthcare clinics | Health Services |
Option Care Health, Inc.
Option Care Health, Inc. Medical/Nursing ServicesHealth Services Provides home and alternate site infusion services | Health Services |
Shields Specialty Pharmacy Holdings LLC
Shields Specialty Pharmacy Holdings LLC Part of Shields Health Solutions Holdings LLC, Shields Specialty Pharmacy Holdings LLC is a specialty pharmacy integrator and accelerator that partners with health systems to improve patient outcomes and expand access to specialty medications for chronic, complex, and rare diseases. The company is based in Stoughton. The American company offers an integrated, patient-centered care model supported by clinical teams and proprietary technology, including the telemetryrx® platform, which uses data analytics to enhance medication adherence, therapy management, and payer access. Shields provides services such as specialty pharmacy operations, pharmaceutical pipeline management, payer contracting, trade relations, 340b strategy, revenue cycle support, and compliance monitoring. The company manages limited distribution drugs and complex therapies for conditions like hereditary angioedema, myasthenia gravis, pulmonary arterial hypertension, multiple sclerosis, hepatitis c, hiv, and rheumatoid arthritis. Shields collaborates with health systems to build and accelerate specialty pharmacy programs, optimize drug launches, and improve clinical and financial outcomes. |
















